Working With Us

We actively seek and support promising research that advances understanding and treatment of:

• Alpha-1 Antitrypsin Deficiency in all its manifestations
• Comorbidities and related conditions linked to AAT deficiency
• Novel therapeutic applications of Alpha-1 Antitrypsin
• All conditions identified in Mark Egly's comprehensive patent filing
• Diagnostic innovations that improve early detection
• Quality of life improvements for patients and caregivers

We bring the patient perspective to every research initiative. Our foundation is built on lived experience, and we ensure that research priorities align with the real needs of the Alpha-1 community.

Mark Egly's pioneering research has identified connections between AATD and over 152 autoimmune diseases, creating an unprecedented research landscape. We provide access to this groundbreaking framework that can guide innovative studies.

With direct ties to the Alpha-1 patient community, we can:

• Facilitate patient recruitment for clinical trials
• Provide real-world insights into disease progression and symptoms
• Gather patient-reported outcomes and experiences
• Build awareness and participation in research initiatives

We believe the best research emerges from collaboration. We actively foster connections between:

• Academic researchers and clinical practitioners
• Pharmaceutical companies and non-profit organizations
• Geneticists, pulmonologists, hepatologists, and specialists across disciplines
• International research teams working on Alpha-1

We work with researchers in ways that fit their needs:

• Direct research funding and grants
• Co-sponsorship of larger studies
• Data sharing and patient registry access
• Community engagement and awareness support
• Advocacy for regulatory pathways and policy changes

Clinical Trials Support

• Patient recruitment assistance
• Community education about trial opportunities
• Long-term follow-up coordination
• Patient advocacy and retention support

Observational Studies

• Access to patient populations
• Survey distribution and data collection
• Longitudinal study facilitation
• Real-world evidence gathering

Molecular & Genetic Studies

• Investigation of SERPINA1 gene variants
• Protein folding and function research
• Genetic modifier identification
• Novel allele characterization

Disease Mechanism Research

• Inflammatory pathway studies
• Multi-organ system investigations
• Comorbidity connection research
• Preventive intervention studies

Therapeutic Development

• Novel drug target identification
• Augmentation therapy improvements
• Gene therapy approaches
• Personalized medicine strategies

Diagnostic Innovation

• Biomarker discovery
• Screening method development
• Point-of-care testing
• Newborn screening optimization

Care Delivery Models

• Treatment access and adherence studies
• Healthcare utilization patterns
• Cost-effectiveness analyses
• Health equity investigations

Patient & Caregiver Studies

• Quality of life assessments
• Psychosocial impact research
• Caregiver burden and support
• Patient education effectiveness

Step 1: Reach OutContact our research team to discuss your project concept, research goals, and how the Foundation might support your work.

Step 2: Exploratory MeetingWe'll schedule a conversation to explore alignment between your research priorities and our mission, discuss collaboration possibilities, and identify resources we can provide.

Step 3: Proposal DevelopmentFor formal partnerships, we'll work with you to develop a detailed proposal outlining objectives, methods, timeline, budget, and expected outcomes.

Research Proposals Should Include:

• Clear research questions and hypotheses
• Methodology and study design
• Expected timeline and milestones
• Budget and resource requirements
• IRB approval status or plan
• Patient engagement strategy
• Dissemination plan for findings
• Potential impact on Alpha-1 community

Foundation Support May Include:

• Financial support through grants or sponsorship
• Patient recruitment and community outreach
• Access to patient registries and databases
• Educational materials for study participants
• Advocacy support for research priorities
• Collaboration with other researchers in our network
• Amplification of research findings through our platforms
• Ongoing consultation and partnership throughout the study

While we support diverse research approaches, we're especially interested in projects that:

• Universal newborn screening implementation
• Rare allele characterization and clinical impact
• Long-term outcomes of early intervention
• Non-pulmonary manifestations of AATD

• Connections between AATD and autoimmune diseases
• AAT's protective role across organ systems
• Novel therapeutic applications of AAT protein
• Genetic and environmental interactions

• Early diagnosis strategies
• Treatment optimization
• Quality of life interventions
• Reduced diagnostic odyssey duration

• Screening in underrepresented populations
• Access to care barriers
• Cultural and linguistic appropriate interventions
• Global AATD awareness and diagnosis

The Mark Egly Foundation is committed to:

• Patient Privacy: All research must comply with HIPAA and data protection regulations
• Informed Consent: Clear, understandable consent processes for all participants
• Ethical Review: IRB approval for human subjects research
• Transparency: Open communication about research goals, methods, and findings
• Data Integrity: Rigorous scientific standards and reproducible methods
• Publication: Support for peer-reviewed publication of findings
• Community Benefit: Research that ultimately serves the Alpha-1 community

While the Mark Egly Foundation is establishing its research program, we're building on the strong foundation of Mark's groundbreaking work. His patent filing alone has opened countless research directions that will keep the scientific community engaged for years to come.

We're just getting started, and we want you to be part of this journey.

Ready to explore a partnership? Have questions about working with us? Want to share preliminary findings or discuss a research idea?

Contact Us:[Contact information to be added]

Research Newsletter:Subscribe to receive updates on research initiatives, funding opportunities, and Alpha-1 scientific advances.

Researcher Network:Join our growing community of Alpha-1 investigators for collaboration opportunities, knowledge sharing, and joint projects.

For the millions of people worldwide living with undiagnosed Alpha-1 Antitrypsin Deficiency, your research represents hope. For families seeking answers, your work provides clarity. For future generations, your discoveries create possibilities.

Let's work together to transform Alpha-1 care.

"Science advances fastest when we combine rigorous research with deep compassion for those we serve."— In honor of Mark Egly, researcher, advocate, and inspiration